dc.contributor.author | Caputo, S. | |
dc.contributor.author | Solje, K. S. | |
dc.contributor.author | Svendsen, A. L. | |
dc.contributor.author | Pan, C. | |
dc.contributor.author | Orozco-Beltran, D. | |
dc.contributor.author | Vora, J. | |
dc.contributor.author | Damci, T. | |
dc.contributor.author | Khunti, K. | |
dc.date.accessioned | 2021-03-05T09:48:54Z | |
dc.date.available | 2021-03-05T09:48:54Z | |
dc.date.issued | 2014 | |
dc.identifier.citation | Vora J., Caputo S., Damci T., Orozco-Beltran D., Pan C., Svendsen A. L. , Solje K. S. , Khunti K., "Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes", JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, cilt.39, ss.136-143, 2014 | |
dc.identifier.issn | 0269-4727 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_9fc1c1dd-0e06-4fc6-a790-c45868ee2192 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/107209 | |
dc.identifier.uri | https://doi.org/10.1111/jcpt.12116 | |
dc.description.abstract | What is known and objective | |
dc.language.iso | eng | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Eczacılık | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.title | Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | |
dc.contributor.department | Royal Liverpool & Broadgreen University Hospitals NHS Trust , , | |
dc.identifier.volume | 39 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 136 | |
dc.identifier.endpage | 143 | |
dc.contributor.firstauthorID | 214136 | |